12-15 May 2025
Congress Center HamburgHamburg, GermanyMr Mark DuerkopChief Executive Officer at Novasign, AustriaSpeaker
Profile
Dr. Mark Duerkop is co-founder and CEO of Novasign GmbH a spin-off from the University of Natural Resources and Life Sciences in Vienna focusing on accelerating bioprocess development by application of advanced machine learning tools. Within the last years Mark developed a hybrid modeling software with his team that help bioprocess engineers to better understand their processes while additionally reducing the experimental effort to find process optima.
Agenda Sessions
Digitalization in Biopharma
, 11:00View SessionAccelerating Bioprocess Development: Intensified and Model-Based Design of Experiments for Faster, Cost-Effective Production
, 13:30View SessionSmart Workflows: From Planning to Actionable Insights – How Digital Process Twins Drive Decision-Making in Industry 4.0
, 14:50View Session